10 things you need to know this morning in Australia James Hennessy
1.
Big corporates including banks, large mining companies and others will be asked to vaccinate their staff later in the year, as the rollout finally picks up pace. Australia currently lags behind other developed countries in vaccination, and state leaders including Gladys Berejiklian and Daniel Andrews say supplies are too low to meet demand.
2.
South-east Queensland has joined NSW, WA and the Northern Territory in the lockdown club as of today. People in 11 government areas (Noosa, Sunshine Coast, Ipswich, Logan, Redlands, Brisbane, Gold Coast, Scenic Rim, Lockyer Valley, Moreton Bay and Somerset) are only allowed to leave their homes for four reasons. You know the drill by now.
Australian LGP in Cannabis flower deal with Medezin
A FIVE-YEAR exclusive pharmaceutical distribution agreement has been signed between South West-based Little Green Pharma (LGP) and Medezin for the distribution of cannabis medicines into Poland.
Medezin is a subsidiary of Pelion SA – the largest operator in the Polish and Lithuanian healthcare sector – and is now the exclusive partner for the distribution of LGP’s medicinal cannabis oil and high tetrahydrocannabinol (THC) flower products in Poland.
Medezin is targeting the sale of products equivalent to at least 20 per cent of the Polish medicinal cannabis oil market and at least 10pc of the Polish high-THC medicinal cannabis flower Market.
2 cannabis companies are making major moves in the Aussie market. They say Australia is ‘uniquely positioned’ to become a global leader. Bianca Healey Credit: Getty
Last week, two cannabis companies with significant international footprints made major moves in the Australian market.
Since the import and sale of pharmaceutical-grade cannabis was legalised in 2016, companies have been negotiating strict TGA guidelines to enter what they see as a potentially enormous growth market.
“Australia is setting the benchmark” for the global manufacture and trade of cannabis, Fleta Solomon, managing director of Western Australia-based cannabis firm Little Green Pharma, told Business Insider Australia.
Last week, two players in the global pharmaceutical cannabis market announced major moves and fundraising in the Australian market, signalling that local growth in the sector is picking up speed.
Why the Little Green Pharma (ASX:LGP) share price fired up 8% today fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
The
Little Green Pharma Ltd(ASX: LGP) share price has fallen more than 16% this morning after the company announced a $22 million share placement. At the time of writing, the Little Green Pharma share price is trading at 78 cents, down 16.58%.
What’s driving the Little Green Pharma share price?
Yesterday, the company announced its first exports of cannabis flower medicines to Germany. Little Green Pharma has manufactured Australian medical-grade cannabis products since August 2018.
The company today advised it has received ‘firm commitments’ to raise approximately $22 million (before costs). This will be executed via a share placement program for sophisticated, experienced and professional investors.